Join industry experts from PRISYM ID and GS1 to learn about the new GS1 Clinical Trial barcode standards and the benefits of adopting AI (7240).
PRISYM ID introduces an InDesign Plugin to its life science dedicated label and artwork management platform, PRISYM 360.
PRISYM ID’s compliant labelling solution, PRISYM 360, has been selected by CME Ltd to ensure delivery of just in time clinical trials for the Medicines Manufacturing Innovation Centre project.
PRISYM ID will be exhibiting at the Clinical Trial Supply East Coast 2019 on the 16th and 17th of October, in King of Prussia, booth 16.
Here’s a blog about the new GS1 Standard for Clinical Trials and how we can help you adopt it
Changing regulations, such as Annex VI clinical trial regulation, need to be incorporated into the label and artwork processes in time for when the regulation takes effect.
PRISYM ID will proudly be exhibiting at this year’s Pharma and Device Packaging and Labelling Europe event on 10th and 11th September 2019.
The imminence of Annex VI will have a resounding impact upon the clinical trial industry, adding further complexity to the existing compliance legislation.
Annex VI EU No 536/2014 is a clinical trial regulation which will impose new labeling challenges to the industry.
Are your current packaging and labeling processes preventing you from creating a faster, more flexible supply chain?